Human Tissue Authority

The regulator for human tissue and organs

Operational preparedness and continuity of supply

Our shared focus should be on mitigating any potential disruption to supply including, but not limited to:

  • medicines, vaccines, medical devices and clinical consumables;
  • blood and other products of human origin including tissues, cells and organs; and
  • non-clinical consumables, goods and services; workforce; and research and clinical trials.

You should consider the transport of tissues and cells to and from the EU and European Economic Area (EEA) and your requirements for, and the supply of, consumables and reagents required to carry out your work.

If you are a licensed establishment within the NHS, you should ensure that your supply needs have been considered in preparation for the end of the transition period.

If you work outside of the NHS, you will also need to be working with your partners and suppliers to ensure as little disruption as possible to your supply chain.

It is important that you maintain the integrity of your supply chain through agreements with your suppliers and have contingency measures in place in case of any issues.


Last updated on: 31 Dec 2020